Stroke

Camm, Prof. J., London, United Kingdom

Factor Xa inhibition in stroke prevention in AF

Lip, Prof. G. Y. H., Birmingham, United Kingdom

Evaluating stroke and bleeding risk in atrial fibrillation: Where are we now?

Patel, Prof. M., Durham, United States

Impact of risk factors on patient outcomes in AF

Kakkar, Prof. A., London, United Kingdom

Reducing the risk of stroke in patients with AF: What can Registries tell us?

Moons, Prof. K. G. M., University Medical Center Utrecht, Utrecht, Netherlands

Excluding venous thromboembolism in a primary care setting using a clinical decision rule and a point-of-care D-dimer assay(Archiv)

02-Sep-08

Messerli, Prof. H., New York, United States

Stroke prevention: not all antihypertensive drugs are created equal(Archiv)

06-Sep-05

Diener, Prof. H.-C., Essen, Germany

Blood pressure control: stroke and stroke prevention(Archiv)

06-Sep-05

Lueders, Prof. S., Cloppenburg, Germany

Principal results of a prospective randomized controlled study: Morbidity and mortality after stroke – Eprosartan compared with nitrendipine for secondary prevention (MOSES)(Archiv)

06-Sep-05

Martinez, Prof. M., Valencia, Spain

Effect of eprosartan on cytoplasmic free calcium mobilization, platelet activation and microparticle formation in hypertension. Relevant to prevent stroke?(Archiv)

06-Sep-05